Welcome to our dedicated page for Arrive AI news (Ticker: ARAI), a resource for investors and traders seeking the latest updates and insights on Arrive AI stock.
Arrive AI Inc. develops autonomous delivery infrastructure centered on patented, AI-powered Arrive Points and its Autonomous Last Mile platform. The system is designed for secure, asynchronous exchange of goods by drones, ground robots, and human couriers, with tracking data, smart logistics alerts, climate-assisted endpoints, and chain-of-custody controls for shippers, delivery services, autonomous networks, healthcare, logistics, and enterprise delivery.
News about ARAI commonly covers financial results, product development, pilot deployments, engineering organization updates, patent activity, investor conference participation, and governance changes. Company updates also include AI and robotics development work, including simulation-driven training and computer vision systems for autonomous delivery environments.
Arrive AI (NASDAQ:ARAI) appointed Ian Geise as Head of Commercialization, effective January 21, 2026. Geise will lead go-to-market strategy, align Sales and Marketing, own pipeline and forecasting, support strategic enterprise deals, and partner with Product, Engineering and Operations to influence roadmap. His background includes national retail launches at Sirius and DIRECTV and commercialization roles at VOXX, including responsibility for a Sirius retail rollout across more than 15,000 points of sale. Geise will be based in Fishers, Indiana and will work on-site with Arrive AI leadership.
Arrive AI (NASDAQ: ARAI) highlighted Indiana's January 15, 2026 designation as a federal Unmanned Aircraft System (UAS) testing site, positioning the company near a national hub for autonomy testing and regulatory validation. The designation links state assets—Camp Atterbury, Muscatatuck, Naval Surface Warfare Center, and Purdue University—with Arrive AI's patented Arrive Points™ infrastructure for secure last‑mile delivery.
Arrive AI says the proximity offers early visibility into evolving FAA frameworks, faster validation of air‑to‑ground workflows, tighter partner integration, and a lower‑friction path from pilots to scaled deployment for regulated and enterprise use cases.
Arrive AI (NASDAQ:ARAI) released its 2025 Year in Review highlighting public‑market milestones, healthcare deployments, partnerships, IP growth, and product acceleration.
Key 2025 items: Nasdaq direct listing and start of trading (May 15, 2025); inclusion in Russell 2000 and 3000 (Oct 20, 2025); an authorized $10 million share repurchase program (announced Sept 8, 2025; through Mar 31, 2026); healthcare deployments with Hancock Health and Go2 Delivery; entry into India via Skye Air Mobility; acceptance into NVIDIA Connect; and expansion to 9 issued U.S. patents with additional filings. The company also opened a ~30,000 sq. ft. headquarters and plans to scale deployments and product development in 2026.
Arrive AI (NASDAQ:ARAI) will attend CES 2026 with leadership, product, and engineering teams to engage industry stakeholders and assess market readiness for autonomous delivery in healthcare and enterprise settings.
The company said its delegation, led by COO Mark Hamm, will prioritize operational readiness, AI for safety and exception handling, integration challenges, and secure chain-of-custody concerns to inform product and platform development.
Arrive AI (NASDAQ:ARAI) reported third quarter 2025 results on November 14, 2025, highlighting early commercial deployments, IP gains, team expansion, and continued investment in product development.
Key facts: Revenue $7,450; Net loss $2.2M (Q3 2024 loss $0.8M); Cash and short-term investments $2.7M after receiving proceeds from a $4M capital facility; hired ~30 employees in Q3 with a year-end hiring goal of 60. Operational milestones include a live hospital robotic delivery pilot at Hancock Health, expanded partnership with Skye Air Mobility in India, new agreements with Synoptek and Ottonomy, and a ninth U.S. patent for the Arrive Point device.
Arrive AI (NASDAQ:ARAI) has relocated to a nearly 30,000 square-foot headquarters in Fishers, Indiana, moving from 12175 Visionary Way to 9100 Fall View Drive on November 10, 2025. The move supports rapid hiring — growth from 6 employees in January to an expected ~60 by year-end — and provides space for prototyping, engineering, and a planned state-of-the-art showroom. The new site sits near The Yard, Top Golf, and Ikea and aims to support scaling through 2026.
Arrive AI (NASDAQ:ARAI) will report third quarter fiscal 2025 results on Friday, November 14, 2025 before the market opens. Following the earnings release, management will host a conference call and webcast at 9:30 AM Eastern Time to review results and strategic progress.
Participants listed include CEO and founder Dan O'Toole, COO Mark Hamm, Chief Strategy Officer Neerav Shah, CFO Todd Pepmeier and Corporate Counsel John Ritchison. The live webcast link and replay will be available via the company website.
Arrive AI (NASDAQ:ARAI) applauded Indiana Governor Mike Braun's October 29, 2025 executive order creating the Indiana Initiative for Drone Dominance Task Force, aimed at coordinating state government, academia, and industry to support federal drone leadership goals. The task force will prioritize safety policy, testing, supply chain, and infrastructure to advance drone deliveries and airspace security. The release cites Indiana strengths including advanced manufacturing, NSWC Crane expertise, restricted testing airspace, and university research and notes the drone sector is estimated at $59 billion by 2030.
Arrive AI (NASDAQ:ARAI) announced a two-year partnership with Ottonomy and Hancock Health on October 28, 2025 to deploy the world's first fully asynchronous robotic deliveries inside a hospital.
The rollout installs Arrive Points across the Sue Ann Wortman Cancer Center, lab and surgical center; Ottobot robots retrieve and deliver specimens to secure receptacles at proper temperatures until staff pickup. A medical assistant reported cutting roughly at least half of her 90+ minutes/day specimen-walking time. Hancock Health said expansion across its >30 locations is likely, and Arrive AI plans to scale integration with ground robotics, couriers and drones.
Arrive AI (NASDAQ:ARAI) announced on October 20, 2025 that it has been added to the Russell 2000 and Russell 3000 indexes.
The company said the inclusion increases its visibility with institutional investors and index funds, and "opens access to a broad base of institutional investors, index funds and ETFs," supporting potential increased liquidity and long-term shareholder value. Management noted the listing means Arrive AI is one of the 3,000 largest publicly traded companies. The company builds an autonomous delivery network using patented AI-powered Arrive Points and a Mailbox-as-a-Service platform.